Budget impact tool for the incorporation of medications for opioid use disorder into jail/prison facilities

Ryan, Danielle; Montoya, Iván D.; Koutoujian, Peter J.; Siddiqi, Kashif; Hayes, Edmond; Jeng, Philip J.; Cadet, Techna; McCollister, Kathryn E.; Murphy, Sean M.

doi:10.1016/j.josat.2022.208943

Cited by 8 publications

(1 citation statement)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For example, offering hepatitis C treatment to everyone who needs it has been challenging because of the cost (>$80,000 per treatment), a recommended treatment period of 8–12 weeks, and high rates of hepatitis C virus infection in jails and prisons ( 22 , 23 ). Other challenges for correctional healthcare budgets are paying for long-acting injectable medications that treat or prevent HIV infection and adopting substance use disorder treatments in jails and prisons ( 24 , 25 ). Many jails and prisons in the United States now offer medications for treatment of opioid use disorder and substance use disorder to prevent the risk for medical complications (e.g., withdrawal and death).…”

Section: Barriers To Care Created By the Miepmentioning

confidence: 99%

Medicaid Inmate Exclusion Policy and Infectious Diseases Care for Justice-Involved Populations

Wurcel,

London,

Crable

et al. 2024

Emerg. Infect. Dis.

Self Cite

View full text Add to dashboard Cite

The Medicaid Inmate Exclusion Policy (MIEP) prohibits using federal funds for ambulatory care services and medications (including for infectious diseases) for incarcerated persons. More than one quarter of states, including California and Massachusetts, have asked the federal government for authority to waive the MIEP. To improve health outcomes and continuation of care, those states seek to cover transitional care services provided to persons in the period before release from incarceration. The Massachusetts Sheriffs’ Association, Massachusetts Department of Correction, Executive Office of Health and Human Services, and University of Massachusetts Chan Medical School have collaborated to improve infectious disease healthcare service provision before and after release from incarceration. They seek to provide stakeholders working at the intersection of criminal justice and healthcare with tools to advance Medicaid policy and improve treatment and prevention of infectious diseases for persons in jails and prisons by removing MIEP barriers through Section 1115 waivers.

show abstract